Challenges for mesenchymal stromal cell therapies.

Martin I; Galipeau J; Kessler C; Le Blanc K; Dazzi F

doi:10.1126/scitranslmed.aat2189

Back

Journal article

Challenges for mesenchymal stromal cell therapies.

Martin I Department of Biomedicine, University Hospital Basel, University of Basel, 4031 Basel, Switzerland. ivan.martin@usb.ch.
Galipeau J Department of Medicine, University of Wisconsin Carbone Comprehensive Cancer Center, Madison, WI 53715, USA.
Kessler C Health Directorate, Directorate General for Research and Innovation, European Commission, 1049 Brussels, Belgium.
Le Blanc K Center for Hematology and Regenerative Medicine, Karolinska University Hospital, 171 77 Stockholm, Sweden.
Dazzi F School of Cancer and Pharmacological Sciences, King's Health Partners Cancer Research UK Centre, King's College London, London SE1 9NH, UK.

2019-02-22

Published in:

Science translational medicine. - 2019

Mesenchymal Stem Cell Transplantation

English Clinical trials of mesenchymal stromal cell therapies reveal a challenging heterogeneous landscape, including diverse therapeutic targets, patient categories, cell sources, and potential mechanisms of action.

Language